Format

Send to

Choose Destination
JAAD Case Rep. 2016 Jul 14;2(3):264-8. doi: 10.1016/j.jdcr.2016.05.002. eCollection 2016 May.

Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.

Author information

1
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
2
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
3
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut; Smilow Cancer Center, Yale University School of Medicine, New Haven, Connecticut.

KEYWORDS:

CTLA-4, cytotoxic T-lymphocyte–associated antigen 4; PD-1, programmed death–1; immune-related adverse events; immunotherapy; irAEs, immune-related adverse events; lung cancer; sarcoidosis

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center